Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
In September, Fresenius Medical Care AG experienced an 8.6% decrease in short interest, while their stock rose to $20.04.
Fresenius Medical Care AG (FMS) experienced an 8.6% drop in short interest in September, totaling 683,300 shares.
The stock rose to $20.04 by September 30.
The company reported earnings per share of $0.38 for the last quarter, in line with estimates, while revenue was $5.13 billion, below expectations.
Analysts have mixed views on FMS, with an average rating of "Hold" and a target price of $23.
The firm specializes in dialysis services for renal disease patients.
3 Articles
En septiembre, Fresenius Medical Care AG experimentó una disminución del 8,6% en el interés corto, mientras que sus acciones aumentaron a $20.04.